Group schematherapy for patients with addiction and comorbid personality disorder. A mixed-methods pilot study of feasibility and clinical potential

Phase 2

• Conditions: stoornis in middelengebruik; addiction; substance abuse; 10034726

• Registration Number: NL-OMON56878
• Lead Sponsor: De Grift (verslavingszorg, Arnhem)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: Pending
• Sex: Not specified
• Target Recruitment: 0

Inclusion Criteria

Participating patients, based on patients* record information:
- Diagnosed with one or more substance use disorders according to DSM-5
criteria.
- Active Substance Use Disorder treatment, at least during groupschematherapy
- Personality Disorder according to DSM-5 criteria (or working hypotheses)
- Age between 18 and 70 years
- At least partial control over substance use; that is, participants can attend
sessions sober.
- Written informed consent.

Exclusion Criteria

based on information from the patients* record there is no evidence of:
- Inadequate proficiency in the Dutch language.
- Severe, untreated ADHD symptoms due to overlapping features with a
personality disorder.
- Psychotic disorder (except for brief reactive psychoses consistent with the
Personality Disorder).
- Neurocognitive functional impairments.
- Bipolar disorder.
- Significant substance use without a desire to achieve abstinence.
- IQ lower than 80

Study & Design

• Study Type: Interventional
• Study Design: Not specified